Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-013434
Filing Date
2022-07-29
Accepted
2022-07-29 07:01:41
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glto-20220630.htm   iXBRL 10-Q 2104290
2 EX-31.1 glto-ex31_1.htm EX-31.1 24353
3 EX-31.2 glto-ex31_2.htm EX-31.2 24374
4 EX-32.1 glto-ex32_1.htm EX-32.1 21700
  Complete submission text file 0000950170-22-013434.txt   6932314

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glto-20220630_lab.xml EX-101.LAB 336158
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glto-20220630_cal.xml EX-101.CAL 42483
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glto-20220630_def.xml EX-101.DEF 114215
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glto-20220630_pre.xml EX-101.PRE 240898
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glto-20220630.xsd EX-101.SCH 35462
56 EXTRACTED XBRL INSTANCE DOCUMENT glto-20220630_htm.xml XML 1316123
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39655 | Film No.: 221117276
SIC: 2834 Pharmaceutical Preparations